openPR Logo
Press release

Infant Clinical Nutrition market are poised to surpass US$ 31,000 Mn by 2026-end

Infant Clinical Nutrition market are poised to surpass US$

According to a recently developed report of Persistence Market Research, a spectacular rise is envisaged for the global infant clinical nutrition market through the forecast period, 2017 to 2026. Revenues from the market are poised to surpass US$ 31,000 Mn by 2026-end.

Emphasis is Rising to Meet Higher Nutritional & Microbiology Standards of Infant Clinical Nutrition

Infants and toddlers requiring special clinical attention and requirements deserve exceptional nutrition, along with high degree of care in their daily food consumption. With the widespread availability of formulations and ingredients that have gained consumer loyalty globally, emphasis is now being placed on meeting higher nutritional and microbiology standards apropos to infant clinical nutrition. Demand for infant clinical nutrition across the globe has witnessed a substantial rise since the recent past, mainly driven by robust birth rates along with growing disposable incomes of consumers. In addition, the female working population has witnessed proliferation, which in turn has fuelled adoption of nutrition-rich and secure infant food products. Some of the notable developments in the infant clinical nutrition market include hypo-allergenic formulas, growing number of infants with special requirements, and premium quality offerings from prominent companies in the market.

Request for Sample Report @ https://www.persistencemarketresearch.com/samples/22363

Clinical trials are being emphasized for assessing effects on preterm infants in experiencing the taste and smell of milk, in order to determine whether girls and boys be fed differently and for testing effects of IGF-1 supplements and insulin on developmental and growth outcomes. Researchers in the field of infant clinical nutrition are directing their focus toward developing new formula products, which would make improvements in metabolic and cognitive outcomes. Emphasis is growing in neonatal care research regarding provision of nutrition-rich diet to preterm infants for enhancing their long-term developmental outcomes.

Oral Route of Administration Segment to Account for Lion’s Share of the Market

Based on route of administration revenues from enteral administration is anticipated to register fastest expansion in the global infant clinical nutrition market through 2026. However, the market revenue share of enteral administration will remain sluggish during the forecast period. In contrast, oral administration of infant clinical nutrition is envisaged to account for the lion’s share of the market during 2017 to 2026.

On the basis of product type, milk-based infant clinical nutrition are likely to remain dominant in the market, in terms of revenues. Revenues from milk-based products are expected to be significant larger than those procured from sales of all the other product segments combined. In addition, revenues from soy-based, organic, and probiotic/prebiotic product segments are collectively estimated to exceed US$ 8,000 Mn by 2026-end.

APEJ to Remain Largest Market for Infant Clinical Nutrition

Asia-Pacific excluding Japan (APEJ) is expected to endure as the largest market for infant clinical nutrition, with sales poised to account for more than two-fifth market revenue share by 2026-end. Europe and North America are also expected to prevail as remunerative markets for infant clinical nutrition. Europe will continue to latch onto its position of being the fastest-growing market for infant clinical nutrition, trailed by APEJ.

Companies in the global market for infant clinical nutrition are implementing novel ingredients in their products, combining application intelligence with innovative techniques of product development. These companies are also focusing on advancing their production processes for reducing the environmental footprint. With efficient up-scaling in the food grade processing centers and supported clinical trials, particularly in the microbiome field, companies are enabled to reinforce their dossiers prior to the presentation to regulatory bodies.

Key companies that actively support expansion of the global infant clinical nutrition market, as identified by the report, include Claris Lifesciences Ltd., B. Braun Melsungen AG, Meiji Co., Ltd., Mead Johnson Nutrition Company, Nutricia North America, Groupe Danone, Fresenius Kabi AG, Baxter International, Inc., Nestlé Health Science S.A., and Abbott.

Requst for Table of Content (ToC): https://www.persistencemarketresearch.com/methodology/22363

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance. To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
Telephone - +1-646-568-7751
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Infant Clinical Nutrition market are poised to surpass US$ 31,000 Mn by 2026-end here

News-ID: 1330622 • Views:

More Releases from Persistence Market Research

IV Fluid Transfer Drug Devices Market to Grow at a CAGR of 3.5% from 2023 to 2030, reaching US$ 8.5 Billion: As per PMR Study
IV Fluid Transfer Drug Devices Market to Grow at a CAGR of 3.5% from 2023 to 203 …
Introduction The IV fluid transfer drug devices market has gained significant momentum in recent years due to its vital role in ensuring safe, accurate, and sterile administration of intravenous therapies across healthcare settings. These devices are designed to facilitate efficient transfer of fluids and medications from containers to patients, minimizing the risk of contamination, dosage errors, and healthcare-associated infections. They are widely used in hospitals, ambulatory surgical centers, homecare, and specialty
Urolithiasis Management Devices Market Set to Grow and Garner a Share of US$ 2.2 Billion by 2030, Affirms Persistence Market Research
Urolithiasis Management Devices Market Set to Grow and Garner a Share of US$ 2.2 …
Introduction The urolithiasis management devices market has witnessed significant growth in recent years, driven by the increasing prevalence of kidney stones and advancements in minimally invasive treatment options. Urolithiasis, or the formation of stones in the urinary tract, is a growing global health concern linked to changing dietary habits, sedentary lifestyles, and rising incidences of metabolic disorders such as obesity and diabetes. Management devices play a crucial role in the diagnosis,
Endoscopic Closure Systems Market Set to Grow at a 6.7% CAGR, Crossing the US$ 487.8 Million Mark by 2030
Endoscopic Closure Systems Market Set to Grow at a 6.7% CAGR, Crossing the US$ 4 …
Introduction The endoscopic closure systems market has witnessed remarkable growth in recent years due to their critical role in minimally invasive surgical procedures. These systems are primarily used to close gastrointestinal perforations, resection sites, fistulas, and leaks, offering a safe and effective alternative to traditional open surgeries. Known for their efficiency, precision, and patient safety benefits, endoscopic closure systems have become indispensable in gastroenterology, bariatric surgery, oncology, and other medical specialties. Request
At-Home Molecular Testing Market to Reach US$16.3 Bn by 2030, Growing at 6.0% CAGR
At-Home Molecular Testing Market to Reach US$16.3 Bn by 2030, Growing at 6.0% CA …
Introduction The at-home molecular testing market has gained remarkable momentum in recent years, driven by the growing demand for accessible, convenient, and accurate diagnostic solutions. Leveraging advanced molecular technologies such as PCR and isothermal amplification, these tests enable users to detect infectious diseases, genetic conditions, and other health-related biomarkers without visiting traditional healthcare facilities. The increasing focus on patient-centric care, rising awareness about preventive health, and technological advancements in miniaturized diagnostic

All 5 Releases


More Releases for Nutrition

Chipotle Nutrition -Your Ideal Nutrition Guide
New Guide Offers In-Depth Breakdown of Chipotle Nutrition, Meal Techniques, and Comparison Tools Consumers seeking to make informed dining choices at Chipotle now have a powerful new resource at their fingertips. This comprehensive guide provides a detailed breakdown of Chipotle's nutritional offerings, effective meal customization techniques, and side-by-side comparisons of popular menu items. Designed with health-conscious and curious eaters in mind, the guide also includes practical tools to calculate nutritional values and
Medical Nutrition Market Seeking Excellent Growth | Nutricia, Mead Johnson Nutri …
Advance Market Analytics added research publication document on Worldwide Medical Nutrition Market breaking major business segments and highlighting wider level geographies to get deep dive analysis on market data. The study is a perfect balance bridging both qualitative and quantitative information of Worldwide Medical Nutrition market. The study provides valuable market size data for historical (Volume** & Value) from 2018 to 2022 which is estimated and forecasted till 2028*. Some
Clinical Nutrition Market Analysis - By Product Type ( Infant Nutrition, Enteral …
Clinical nutrition incorporates the use of specific nutrition for the treatment of an injury, illness or a medical condition. The clinical nutrition aims to articulate a better therapy through nutrition process with the incorporation of specialized nutrition in the patient's treatment. The clinical nutrition helps to lower the risk of developing complications among patients with pre-existing health conditions such as type-2 diabetes. Download Sample PDF at https://www.theinsightpartners.com/sample/TIPRE00007333/?utm_source=OpenPR&utm_medium=10379 Key Players Analysis: Nestle
Medical Nutrition Market Analysis By Type (Pediatric Nutrition, Parenteral Nutri …
The medical nutrition includes modification of diet, education & counseling, intravenous nutrition, tube feeding and medical food. It is generally used by dieticians or doctors as drug complements in conventional therapies. The medical nutrition market is expected to grow in coming years owing to factors such as increasing number of premature birth, rising incidences of chronic diseases, increasing prevalence of malnutrition and others. Download Sample PDF at https://www.theinsightpartners.com/sample/TIPRE00005558/?utm_source=OpenPR&utm_medium=10379 Key Players
2019 Medical Nutrition Market Key Analysis by Major Products - Pediatric Nutriti …
Medical Nutrition market is expected to grow in coming years owing to factors such as increasing number of premature birth, rising incidences of chronic diseases, increasing prevalence of malnutrition and others. Also rise in awareness related to advantage of medicated food among the population is expected to offer opportunities in market growth. The medical nutrition are therapeutic nutritional supplements prescribed to fulfill specific nutritional need of the patient. It addresses the
Medical Nutrition Market Abbott Nutrition, Nestle, Mead Johnson Nutrition Co.
MarketResearchReports.Biz has recently announced the Latest industry research report on: "Global Medical Nutrition Market" : Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts. Earlier medical nutrition solutions were meant for only to address malnutrition, but continued advancements in healthcare has led to the use of these medicated foods to complement drugs to treat various diseases such as diabetes, obesity, renal failure, pediatric malnutrition, sarcopenia and cancer. These